Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Bacteremia peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Bacteremia. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
1 profiles.
2017–2020 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 32 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Bacteremia unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00093067
PeptideScanner retained ClinicalTrials.gov record NCT00093067 at 2026-11-15T22:01:45.056Z. Its registry update date was 2017-02-13, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- February 13, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01191840
PeptideScanner retained ClinicalTrials.gov record NCT01191840 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-01-05, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- January 5, 2018
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01728376
PeptideScanner retained ClinicalTrials.gov record NCT01728376 at 2026-11-15T22:01:45.056Z. Its registry update date was 2018-08-28, and PeptideScanner's reviewed identity mapping was daptomycin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- August 28, 2018
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Daptomycin · 2020-09-22
ClinicalTrials.gov record NCT02972983
Completed at the retained observation.
Open attributed record →Daptomycin · 2018-08-28
ClinicalTrials.gov record NCT01728376
Completed at the retained observation.
Open attributed record →Daptomycin · 2018-02-01
ClinicalTrials.gov record NCT02660346
Completed at the retained observation.
Open attributed record →Daptomycin · 2018-01-05
ClinicalTrials.gov record NCT01191840
Completed at the retained observation.
Open attributed record →Daptomycin · 2017-02-13
ClinicalTrials.gov record NCT00093067
Completed at the retained observation.
Open attributed record →